UK markets close in 4 hours 37 minutes

NGM Biopharmaceuticals Inc (0IK.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.44000.0000 (0.00%)
As of 08:30PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-142,375
-142,375
-162,667
-120,335
-102,487
-
Depreciation & amortisation
2,221
2,221
4,035
6,089
6,555
-
Stock-based compensation
28,719
28,719
32,383
26,242
15,651
-
Change in working capital
-18,376
-18,376
-20,712
4,208
-3,700
-
Accounts payable
-4,977
-4,977
3,207
-4,417
910
-
Other working capital
-133,454
-133,454
-146,297
-74,913
-85,375
-
Other non-cash items
3,161
3,161
2,453
7,053
613
-
Net cash provided by operating activities
-132,202
-132,202
-144,439
-73,229
-83,496
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,252
-1,252
-1,858
-1,684
-1,879
-
Purchases of investments
-105,431
-105,431
-272,857
-293,466
-177,655
-
Sales/maturities of investments
220,970
220,970
289,037
223,500
128,536
-
Net cash used for investing activities
114,287
114,287
14,322
-71,650
-50,998
-
Cash flows from financing activities
Common stock issued
0
0
0
134,580
0
-
Common stock repurchased
-
-
-
-
0
0
Other financing activities
-
-
-
196
-613
-
Net cash used provided by (used for) financing activities
1,775
1,775
54,233
149,657
35,538
-
Net change in cash
-16,140
-16,140
-75,884
4,778
-98,956
-
Cash at beginning of period
77,410
77,410
153,294
148,516
247,472
-
Cash at end of period
61,270
61,270
77,410
153,294
148,516
-
Free cash flow
Operating cash flow
-132,202
-132,202
-144,439
-73,229
-83,496
-
Capital expenditure
-1,252
-1,252
-1,858
-1,684
-1,879
-
Free cash flow
-133,454
-133,454
-146,297
-74,913
-85,375
-